CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in NAUT — Nautilus Biotechnology, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in NAUT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$231,289
+$131,915 QoQ
Shares Held
123,684
+7.2% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 93 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAUT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. NAUT ranks #283 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in NAUT
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $231,289 | 123,684 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $99,374 | 115,418 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $193,588 | 115,231 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $391,837 | 137,487 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $321,719 | 137,487 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $400,880 | 136,354 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $407,698 | 136,354 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $459,710 | 145,478 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $533,347 | 137,816 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $364,540 | 131,603 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $228,610 | 127,006 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $269,252 | 127,006 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $341,646 | 127,006 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $96,591 | 22,256 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $115,286 | 22,256 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $136,651 | 22,256 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||